CCL2 and Hyperkeratosis: Taken together, these results imply that EEFR can suppress the production of TNF-α, IFN-γ, IL-6, and MCP-1, and thus, inhibit epidermal hyperplasia, hyperkeratosis, and immune cell infiltration.